院外における細菌感染性肺炎(Community-Acquired Bacterial Pneumonia):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2441CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:111
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における院外における細菌感染性肺炎(Community-Acquired Bacterial Pneumonia) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 院外における細菌感染性肺炎(Community-Acquired Bacterial Pneumonia)
  - 当レポートの概要
・院外における細菌感染性肺炎(Community-Acquired Bacterial Pneumonia):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Community-Acquired Bacterial Pneumonia Global Clinical Trials Review, H2, 2014″ provides data on the Community-Acquired Bacterial Pneumonia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Community-Acquired Bacterial Pneumonia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Community-Acquired Bacterial Pneumonia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Community-Acquired Bacterial Pneumonia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Community-Acquired Bacterial Pneumonia 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Community-Acquired Bacterial Pneumonia 31
Sep 25, 2014: Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Actavis plc 32
Clinical Trial Overview of Actavis plc 32
Cempra, Inc. 33
Clinical Trial Overview of Cempra, Inc. 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Cempra Pharmaceuticals, Inc. 35
Clinical Trial Overview of Cempra Pharmaceuticals, Inc. 35
AstraZeneca PLC 36
Clinical Trial Overview of AstraZeneca PLC 36
Nabriva Therapeutics AG 37
Clinical Trial Overview of Nabriva Therapeutics AG 37
Cubist Pharmaceuticals, Inc. 38
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 38
Boehringer Ingelheim Auslandsbeteiligungs GmbH 39
Clinical Trial Overview of Boehringer Ingelheim Auslandsbeteiligungs GmbH 39
Bayer AG 40
Clinical Trial Overview of Bayer AG 40
Basilea Pharmaceutica AG 41
Clinical Trial Overview of Basilea Pharmaceutica AG 41
Clinical Trial Overview of Top Institutes / Government 42
Yokohama Rosai Hospital 42
Clinical Trial Overview of Yokohama Rosai Hospital 42
Nagasaki Evaluation Organization for Clinical Interventions 43
Clinical Trial Overview of Nagasaki Evaluation Organization for Clinical Interventions 43
Central Japan Lung Study Group 44
Clinical Trial Overview of Central Japan Lung Study Group 44
Albany Medical Center 45
Clinical Trial Overview of Albany Medical Center 45
Five Key Clinical Profiles 46
Appendix 109
Abbreviations 109
Definitions 109
Research Methodology 110
Secondary Research 110
About GlobalData 111
Contact Us 111
Disclaimer 111
Source 111

List of Tables
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Community-Acquired Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2014* 32
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2014* 33
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 34
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra Pharmaceuticals, Inc., 2014* 35
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 36
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nabriva Therapeutics AG, 2014* 37
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014* 38
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim Auslandsbeteiligungs GmbH, 2014* 39
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 40
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Basilea Pharmaceutica AG, 2014* 41
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama Rosai Hospital, 2014* 42
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagasaki Evaluation Organization for Clinical Interventions, 2014* 43
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Central Japan Lung Study Group, 2014* 44
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials Market, Global, Clinical Trials by Albany Medical Center, 2014* 45

List of Figures
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 15
Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Community-Acquired Bacterial Pneumonia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Community-Acquired Bacterial Pneumonia to Infectious Disease Clinical Trials, E7 Countries (%), 2014* 18
Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Community-Acquired Bacterial Pneumonia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Community-Acquired Bacterial Pneumonia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Community-Acquired Bacterial Pneumonia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Community-Acquired Bacterial Pneumonia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 110

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[院外における細菌感染性肺炎(Community-Acquired Bacterial Pneumonia):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆